Search results
- Regulatory news (469) Apply Regulatory news filter
- Press releases (246) Apply Press releases filter
- Basic page (60) Apply Basic page filter
- Corporate presentations (29) Apply Corporate presentations filter
- Pipeline (26) Apply Pipeline filter
- Shareholder meeting (24) Apply Shareholder meeting filter
- Team member (23) Apply Team member filter
- Videos (16) Apply Videos filter
- Webcasts and audio (14) Apply Webcasts and audio filter
- Financial reports (13) Apply Financial reports filter
- Analyst (11) Apply Analyst filter
- Event (6) Apply Event filter
- Investor contact (5) Apply Investor contact filter
- Research (3) Apply Research filter
- Financial calendar (1) Apply Financial calendar filter
- Webform (1) Apply Webform filter
Dr Frank Mathias to join Oxford Biomedica as new CEO on 27 March 2023
Dr Mathias brings a wealth of experience in innovation, contract development and manufacturing to Oxford Biomedica
Oxford Biomedica confirms no exposure to SVB receivership
Oxford, UK – 13 March 2023: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a leading gene and cell therapy